Fetal Origin of Male Reproductive Disorders

男性生殖疾病的胎儿起源

基本信息

  • 批准号:
    7100943
  • 负责人:
  • 金额:
    $ 39.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-08-01 至 2010-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Epidemiological and experimental studies suggest that disruption of embryonic programming and gonadal development during human fetal life can result in testicular dysgenesis, manifested as undescended testis, hypospadias, poor semen quality, and testicular cancer. Preliminary data indicates that exposure of Leydig cells to low and environmentally relevant concentrations of di-(2-ethylhexyl) phthalate (DEHP) in vivo and mono-ethylhexyl phthalate (MEHP) in vitro altered the genomic and proteomic profile of the cells in a manner that parallels the inhibition of hormone-dependent steroid formation and the induction of Leydig cell hyperplasia. The central objective of this proposal is to gain greater understanding of the fetal basis of male reproductive disorders by elucidating the mechanisms by which exposure of the fetus to the environmental antiandrogen DEHP suppresses fetal testosterone production and later, testosterone and estradiol production by the adult. Our major goals are to identify the cellular targets and the molecular mechanisms underlying the responses of the fetus to DEHP, and to reveal the mechanisms by which effects on the fetus lead to pathologies of the male reproductive tract in the adult. The overarching hypothesis is that in utero exposures to DEHP suppress fetal testosterone production by direct effects on fetal Leydig cells and/or on the mesenchymal cells that are the precursors of adult Leydig cells, and by doing so, suppresses postnatal development and function of the adult Leydig cell population. We will test this hypothesis with the following specific aims: (1) identify the cellular and molecular targets of gestational DEHP in the fetal testis; (2) identify the mechanism(s) by which gestational exposure to DEHP results in reduced testosterone production by the fetal testis; and (3) determine the effects of fetal exposure to DEHP on the formation and function of the adult population of Leydig cells and its impact on testicular function in the immature and adult testis. We believe that these Aims will identify the molecular signaling pathways and characterize their role in mediating the hyperplasic and antiandrogenic effect of phthalates leading to testicular dysgenesis in the adult. Taken together the proposed studies will unveil the endocrine disruptor-sensitive steps in the steroidogenic pathway that are affected by this antiandrogen, and the mechanisms and consequences of endocrine disruption on the endocrine milieu of the adult.
描述(申请人提供):流行病学和实验研究表明,人类胎儿时期胚胎编程和性腺发育的中断可导致睾丸发育不全,表现为睾丸下垂、尿道下裂、精液质量差和睾丸癌。初步数据表明,低浓度的邻苯二甲酸二乙基己酯(DEHP)和邻苯二甲酸单乙基己酯(MEHP)在体内暴露于与环境相关的低浓度邻苯二甲酸二乙基己酯(DEHP),体外暴露于邻苯二甲酸单乙基己酯(MEHP),改变了细胞的基因组和蛋白质组特征,与抑制激素依赖的类固醇形成和诱导间质细胞增殖的方式平行。这项建议的中心目标是通过阐明胎儿暴露在环境抗雄激素DEHP中抑制胎儿睾酮产生以及随后成人产生睾酮和雌二醇的机制,更好地了解男性生殖障碍的胎儿基础。我们的主要目标是确定胎儿对DEHP反应的细胞靶点和分子机制,并揭示对胎儿的影响导致成人男性生殖道病变的机制。最重要的假设是,在宫内暴露于DEHP会直接作用于胎儿间质细胞和/或作为成人间质细胞前体的间质细胞,从而抑制胎儿睾酮的产生,从而抑制成年间质细胞群体的出生后发育和功能。我们将通过以下具体目标来验证这一假说:(1)确定妊娠DEHP在胎儿睾丸中的细胞和分子靶点;(2)确定妊娠暴露于DEHP导致胎儿睾丸产生睾酮减少的机制(S);以及(3)确定胎儿暴露于DEHP对成年间质细胞群形成和功能的影响及其对未成熟和成年睾丸睾丸功能的影响。我们相信,这些目标将确定分子信号通路,并表征它们在介导邻苯二甲酸酯导致成人睾丸发育不全的增生性和抗雄激素效应中的作用。综上所述,拟议的研究将揭示类固醇生成途径中受这种抗雄激素影响的内分泌干扰物敏感步骤,以及内分泌干扰对成人内分泌环境的机制和后果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Vassilios Papadopoulos其他文献

Vassilios Papadopoulos的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Vassilios Papadopoulos', 18)}}的其他基金

The XXVth North American Testis Workshop, Lifelong Cell-Cell Interactions in the Testis: A Driver for Male Fertility
第二十五届北美睾丸研讨会,睾丸中的终身细胞间相互作用:男性生育力的驱动因素
  • 批准号:
    9757545
  • 财政年份:
    2019
  • 资助金额:
    $ 39.95万
  • 项目类别:
FERROUS-MEDIATED DHEA IN ALZHEIMER'S DISEASE
亚铁介导的 DHEA 在阿尔茨海默病中的作用
  • 批准号:
    7608459
  • 财政年份:
    2007
  • 资助金额:
    $ 39.95万
  • 项目类别:
Fetal Origin of Male Reproductive Disorders
男性生殖疾病的胎儿起源
  • 批准号:
    7409634
  • 财政年份:
    2005
  • 资助金额:
    $ 39.95万
  • 项目类别:
Fetal Origin of Male Reproductive Disorders
男性生殖疾病的胎儿起源
  • 批准号:
    7515046
  • 财政年份:
    2005
  • 资助金额:
    $ 39.95万
  • 项目类别:
Fetal Origin of Male Reproductive Disorders
男性生殖疾病的胎儿起源
  • 批准号:
    7176488
  • 财政年份:
    2005
  • 资助金额:
    $ 39.95万
  • 项目类别:
Fetal Origin of Male Reproductive Disorders
男性生殖疾病的胎儿起源
  • 批准号:
    7626376
  • 财政年份:
    2005
  • 资助金额:
    $ 39.95万
  • 项目类别:
Fetal Origin of Male Reproductive Disorders
男性生殖疾病的胎儿起源
  • 批准号:
    6966407
  • 财政年份:
    2005
  • 资助金额:
    $ 39.95万
  • 项目类别:
Fetal Origin of Male Reproductive Disorders
男性生殖疾病的胎儿起源
  • 批准号:
    7232097
  • 财政年份:
    2005
  • 资助金额:
    $ 39.95万
  • 项目类别:
DHEA-AD
DHEA-AD
  • 批准号:
    7376165
  • 财政年份:
    2005
  • 资助金额:
    $ 39.95万
  • 项目类别:
Plasma Diagnostic for Alzheimer's Disease Pathology
阿尔茨海默病病理学的血浆诊断
  • 批准号:
    6788510
  • 财政年份:
    2004
  • 资助金额:
    $ 39.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了